GlassScriptPhysician profile
Jeffrey Deygoo
NPI 1275920720
$10,766.65
in general payments reported to CMS, 2019-2025
17 companies · $159 in 2025
The $159 reported for 2025 was less than what a typical Interventional Pain Medicine provider received nationally (typical 2025 total: $676).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $441 · 2020: $429 · 2021: $1,378 · 2022: $5,063 · 2023: $2,772 · 2024: $525 · 2025: $159.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,153 · Travel and Lodging: $1,303.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,152.80 |
| Travel and Lodging | $1,302.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $2,856.29 | 2020-2025 | Proclaim, Axium, Octrode |
| Boston Scientific Corporation | $2,723.29 | 2019-2023 | |
| Medtronic, INC. | $1,626.95 | 2022-2024 | Venaseal, Intellis Adaptivestim |
| Relievant Medsystems, INC. | $1,104.96 | 2020-2023 | Intracept |
| Vertos Medical, INC. | $625.56 | 2022-2023 | Mild Device Kit |
| Medtronic USA, INC. | $308.01 | 2019-2020 | |
| Biotronik Nro, INC. | $302.40 | 2024 | Prospera |
| Nalu Medical, INC. | $296.53 | 2021 | |
| Nevro Corp. | $154.15 | 2021-2024 | Senza |
| Stryker Corporation | $145.04 | 2023 | Spinejack |
| Mml US, INC. | $140.06 | 2023 | Reactiv8 |
| Saluda Medical Americas, INC. | $136.29 | 2023 | Evoke Scs |
| Painteq LLC | $113.67 | 2022 | |
| Curonix LLC | $99.56 | 2024 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Tactile Systems Technology INC | $80.59 | 2024-2025 | Flexitouch Plus, Nimbl, Entre Plus |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Si-Bone, INC. | $28.57 | 2024 | |
| Bioventus LLC | $24.73 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeffrey Deygoo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.